239 related articles for article (PubMed ID: 9660982)
1. Famciclovir and valaciclovir differ in the prevention of herpes simplex virus type 1 latency in mice: a quantitative study.
Thackray AM; Field HJ
Antimicrob Agents Chemother; 1998 Jul; 42(7):1555-62. PubMed ID: 9660982
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of famciclovir and valaciclovir on the pathogenesis of herpes simplex virus in a murine infection model including reactivation from latency.
Thackray AM; Field HJ
J Infect Dis; 1996 Feb; 173(2):291-9. PubMed ID: 8568288
[TBL] [Abstract][Full Text] [Related]
3. The comparative effects of famciclovir and valacyclovir on herpes simplex virus type 1 infection, latency, and reactivation in mice.
LeBlanc RA; Pesnicak L; Godleski M; Straus SE
J Infect Dis; 1999 Sep; 180(3):594-9. PubMed ID: 10438344
[TBL] [Abstract][Full Text] [Related]
4. Comparison of efficacies of famciclovir and valaciclovir against herpes simplex virus type 1 in a murine immunosuppression model.
Field HJ; Tewari D; Sutton D; Thackray AM
Antimicrob Agents Chemother; 1995 May; 39(5):1114-9. PubMed ID: 7625798
[TBL] [Abstract][Full Text] [Related]
5. Early therapy with valaciclovir or famciclovir reduces but does not abrogate herpes simplex virus neuronal latency.
Field HJ; Thackray AM
Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):461-70. PubMed ID: 10772727
[TBL] [Abstract][Full Text] [Related]
6. Comparison of effects of famciclovir and valaciclovir on pathogenesis of herpes simplex virus type 2 in a murine infection model.
Thackray AM; Field HJ
Antimicrob Agents Chemother; 1996 Apr; 40(4):846-51. PubMed ID: 8849238
[TBL] [Abstract][Full Text] [Related]
7. The effects of antiviral therapy on the distribution of herpes simplex virus type 1 to ganglionic neurons and its consequences during, immediately following and several months after treatment.
Thackray AM; Field HJ
J Gen Virol; 2000 Oct; 81(Pt 10):2385-2396. PubMed ID: 10993926
[TBL] [Abstract][Full Text] [Related]
8. Further evidence from a murine infection model that famciclovir interferes with the establishment of HSV-1 latent infections.
Thackray AM; Field HJ
J Antimicrob Chemother; 2000 Jun; 45(6):825-33. PubMed ID: 10837437
[TBL] [Abstract][Full Text] [Related]
9. Persistence of infectious herpes simplex virus type 2 in the nervous system in mice after antiviral chemotherapy.
Thackray AM; Field HJ
Antimicrob Agents Chemother; 2000 Jan; 44(1):97-102. PubMed ID: 10602729
[TBL] [Abstract][Full Text] [Related]
10. Effect of famciclovir on herpes simplex virus type 1 corneal disease and establishment of latency in rabbits.
Loutsch JM; Sainz B; Marquart ME; Zheng X; Kesavan P; Higaki S; Hill JM; Tal-Singer R
Antimicrob Agents Chemother; 2001 Jul; 45(7):2044-53. PubMed ID: 11408221
[TBL] [Abstract][Full Text] [Related]
11. Effects of famciclovir and valacyclovir on herpes simplex virus type 1 infection, latency, and reactivation in mice: how dissimilar are study results?
Thackray AM; Field HJ
J Infect Dis; 2000 Apr; 181(4):1517-8. PubMed ID: 10762588
[No Abstract] [Full Text] [Related]
12. Temporal pattern of herpes simplex virus type 1 infection and cell death in the mouse brain stem: influence of guanosine nucleoside analogues.
Shaw MM; Gürr WK; Thackray AM; Watts PA; Littler E; Field HJ
J Virol Methods; 2002 Apr; 102(1-2):93-102. PubMed ID: 11879697
[TBL] [Abstract][Full Text] [Related]
13. Valacyclovir in the treatment of herpes simplex, herpes zoster, and other viral infections.
Wu JJ; Brentjens MH; Torres G; Yeung-Yue K; Lee P; Tyring SK
J Cutan Med Surg; 2003; 7(5):372-81. PubMed ID: 14505192
[TBL] [Abstract][Full Text] [Related]
14. Herpes simplex virus latency after direct ganglion virus inoculation.
Hay KA; Edris WA; Gaydos A; Tenser RB
J Neurovirol; 1998 Oct; 4(5):531-8. PubMed ID: 9839650
[TBL] [Abstract][Full Text] [Related]
15. The helicase primase inhibitor, BAY 57-1293 shows potent therapeutic antiviral activity superior to famciclovir in BALB/c mice infected with herpes simplex virus type 1.
Biswas S; Jennens L; Field HJ
Antiviral Res; 2007 Jul; 75(1):30-5. PubMed ID: 17175035
[TBL] [Abstract][Full Text] [Related]
16. Famciclovir or valaciclovir in the management of herpes simplex and varicella zoster infections: an attitudinal survey of clinician perceptions of differential activity.
Smith DE; Gold J
Sex Health; 2007 Jun; 4(2):141-2. PubMed ID: 17524295
[No Abstract] [Full Text] [Related]
17. Herpes simplex virus infection.
Whitley RJ
Semin Pediatr Infect Dis; 2002 Jan; 13(1):6-11. PubMed ID: 12118847
[TBL] [Abstract][Full Text] [Related]
18. Pharmacology of new antiherpes agents: famciclovir and valacyclovir.
Stein GE
J Am Pharm Assoc (Wash); 1997; NS37(2):157-63. PubMed ID: 9069689
[TBL] [Abstract][Full Text] [Related]
19. Comparative efficacy of famciclovir and valacyclovir for suppression of recurrent genital herpes and viral shedding.
Wald A; Selke S; Warren T; Aoki FY; Sacks S; Diaz-Mitoma F; Corey L
Sex Transm Dis; 2006 Sep; 33(9):529-33. PubMed ID: 16540883
[TBL] [Abstract][Full Text] [Related]
20. Effects of antiviral medications on herpetic epithelial keratitis in mice.
Komoto S; Higaki S; Fukuda M; Shimomura Y
Jpn J Ophthalmol; 2015 May; 59(3):194-200. PubMed ID: 25707352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
